Mingjun Rui
Impact in
-
- Cancer Immunotherapy and Biomarkers
- Lung Cancer Research Studies
- HER2/EGFR in Cancer Research
-
- Health Systems, Economic Evaluations, Quality of Life
- Economic and Financial Impacts of Cancer
Papers in
- Oncology 5
- Lung Cancer Research Studies 2
-
- Respiratory viral infections research 2
- Co-authors
- Yingcheng Wang (18 shared papers)Luying Wang (1 shared paper)Ting Zhou (1 shared paper)Aixia Ma (1 shared paper)Hongchao Li (9 shared papers)Haijing Guan (1 shared paper)Yao Zhang (1 shared paper)Ye Shang (6 shared papers)
- Journals
- Frontiers in Public Health (3 papers)Frontiers in Medicine (3 papers)Frontiers in Pharmacology (1 paper)Therapeutic Advances in Medical Oncology (1 paper)Head & Neck (1 paper)
- Partner nations
- ChinaHong KongUnited Kingdom
In The Last Decade
Mingjun Rui
17 papers receiving 289 citations
Peers
Comparison fields: 5 of 55
- Oncology 60
- Economics and Econometrics 39
- Pulmonary and Respiratory Medicine 34
- Otorhinolaryngology 4
- Hepatology 7
Countries citing papers authored by Mingjun Rui
This map shows the geographic impact of Mingjun Rui's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Mingjun Rui with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Mingjun Rui more than expected).
Fields of papers citing papers by Mingjun Rui
This network shows the impact of papers produced by Mingjun Rui. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Mingjun Rui. The network helps show where Mingjun Rui may publish in the future.
Co-authors
The 18 scholars most cited alongside Mingjun Rui, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 21 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | 2021 | 131 | |
| 2 | 2022 | 31 | |
| 3 | 2021 | 29 | |
| 4 | 2021 | 23 | |
| 5 | 2020 | 19 | |
| 6 | 2022 | 15 | |
| 7 | 2021 | 12 | |
| 8 | 2020 | 10 | |
| 9 | 2021 | 4 | |
| 10 | 2025 | 4 | |
| 11 | 2023 | 3 | |
| 12 | 2025 | 3 | |
| 13 | 2022 | 2 | |
| 14 | 2022 | 1 | |
| 15 | 2021 | 1 | |
| 16 | 2025 | 1 | |
| 17 | 2025 | 1 | |
| 18 | 2024 | 1 | |
| 19 | 2025 | 0 | |
| 20 | 2025 | 0 |
About Mingjun Rui
Mingjun Rui is a scholar working on Oncology, Epidemiology, Pulmonary and Respiratory Medicine, Economics and Econometrics and Infectious Diseases, having authored 21 papers that have together received 291 indexed citations. Recurring topics across this work include Health Systems, Economic Evaluations, Quality of Life (3 papers), Lung Cancer Research Studies (2 papers), Cancer Genomics and Diagnostics (2 papers), Respiratory viral infections research (2 papers), Chronic Lymphocytic Leukemia Research (2 papers), Lung Cancer Treatments and Mutations (2 papers), Pharmaceutical Economics and Policy (2 papers) and Clostridium difficile and Clostridium perfringens research (2 papers). The work is most often cited by research in Oncology (60 citations), Economics and Econometrics (39 citations), Pulmonary and Respiratory Medicine (34 citations), Otorhinolaryngology (4 citations) and Hepatology (7 citations). Mingjun Rui has collaborated with scholars based in China, Hong Kong and United Kingdom. Frequent co-authors include Yingcheng Wang, Luying Wang, Ting Zhou, Aixia Ma, Hongchao Li, Haijing Guan, Yao Zhang, Ye Shang, Xueke Zhang and Xin‐Yuan Guan. Their work appears in journals such as Frontiers in Public Health, Frontiers in Medicine, Frontiers in Pharmacology, Therapeutic Advances in Medical Oncology and Head & Neck.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.